<DOC>
	<DOCNO>NCT02728804</DOCNO>
	<brief_summary>This clinical trial study use financial impact assessment tool patient colorectal cancer spread primary site place body . Gathering information patient colorectal cancer time may help doctor good understand financial impact cancer help patient avoid financial problem treatment .</brief_summary>
	<brief_title>S1417 CD Financial Impact Assessment Tool Patients With Metastatic Colorectal Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To estimate incidence treatment-related major financial hardship 12 month , among patient newly diagnose metastatic colorectal cancer ( mCRC ) treat component subcomponents National Cancer Institute ( NCI ) Community Oncology Research Program ( NCORP ) . SECONDARY OBJECTIVES : I . To describe association major financial hardship mCRC treatment demographic factor , include age , race , marital status , employment status , income . II . To explore whether occurrence major financial hardship associate poor health-related quality life time . III . To profile magnitude time treatment-related change patient ' income , asset , debt , employment , quantify major out-of-pocket expense 12 month follow registration . IV . To explore extent health insurance factor ( e.g . high copayments , deductible , premium , loss/change insurance plan ) associate major financial hardship treatment non-adherence . V. To determine feasibility recruit primary caregiver measure caregiver burden caregiver ' perception cancer treatment cost . VI . To determine feasibility conduct prospective-multi-site longitudinal cohort study assess financial outcome patient mCRC undergoing treatment within NCORP network . TERTIARY OBJECTIVES : I . To obtain objective measure expense , debt credit linkage individual patient credit report ( TransUnion ) enrollment ( baseline ) end follow ( 12 month ) . OUTLINE : Patients complete questionnaire ( include Baseline , Financial/Employment Impact , Insurance Impact , Quality Life , Treatment Perceptions questionnaire ) 30-60 minute baseline 3 , 6 , 9 , 12 month . Caregivers complete questionnaire 30-60 minute baseline 6 12 month .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>Patients must newly diagnose metastatic colon rectal cancer ( mCRC ) ( de novo metastatic diagnosis metastatic recurrence ) prior treatment stage IIII disease within 120 day diagnosis time registration Systemic chemotherapy and/or systemic biologic therapy must plan administer within 30 day registration must initiate within 60 day prior registration ; patient plan palliative hospice care ( chemotherapy biologic therapy ) eligible Patients must plan receive treatment register site ; register site must NCORP site Patients must able complete questionnaire English Patients must provide full name , primary address United States ( U.S. ) , birth date social security number registration purpose access credit report data Patients must sign give write informed consent accordance institutional federal guideline As part Oncology Patient Enrollment Network ( OPEN ) registration process treat institution 's identity provide order ensure current ( within 365 day ) date institutional review board approval study enter system</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>